FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, in particular to a vector based on adeno-associated virus (AAV) of serotype 9, containing an expression cassette containing polynucleotide encoding lysosome-associated membrane protein 2B (LAMP-2B), functionally connected to a hybrid promotor containing chicken β-actin promotor and CMV enhancer (CAG promotor).
EFFECT: invention is effective for the treatment of Danon’s disease.
14 cl, 11 dwg, 8 ex
| Title |
Year |
Author |
Number |
| GENE THERAPY VECTORS FOR TREATMENT OF DANON'S DISEASE |
2019 |
- Keravala, Annahita
- Moore, Simon
- Ricks, David
|
RU2808459C2 |
| VERSION OF AAV, COMPOSITIONS AND METHODS IN WHICH IT IS USED, AS WELL AS METHODS OF USING IT FOR TRANSFERRING GENES INTO CELLS, ORGANS AND TISSUES |
2014 |
- High, Katherine A.
- Yazicioglu, Mustafa N.
- Anguela, Xavier
|
RU2837753C2 |
| MODIFIED FACTOR IX, AS WELL AS COMPOSITIONS, METHODS AND OPTIONS FOR THE USE OF GENE TRANSFER INTO CELLS, ORGANS AND TISSUE |
2016 |
- Khaj Ketrin A.
- Angela Khaver
|
RU2811445C2 |
| OPTIMIZED GENES AND EXPRESSION CASSETTES OF MINI-DYSTROPHIN AND THEIR APPLICATION |
2017 |
- Mcphee, Scott W.J.
- Qiao, Chunping
- Li, Juan
- Xiao, Xiao
- Mcintyre, Maritza
- Samulski, Richard J.
|
RU2753194C2 |
| GENE THERAPY FOR THE TREATMENT OF HEMOPHILIA A |
2017 |
- Wang, Lili
- Wilson, James M.
- Sidrane, Jenny Agnes
|
RU2762257C2 |
| ENGINEERED ADENO-ASSOCIATED (AAV) VECTORS FOR TRANSGENE EXPRESSION |
2020 |
- Maguire, Casey A.
- Hudry, Eloise Marie
- Hanlon, Killian S.
|
RU2839774C2 |
| AAV VECTORS AIMED AT THE CENTRAL NERVOUS SYSTEM |
2015 |
|
RU2727015C2 |
| NON-DESTRUCTIVE GENE THERAPY FOR TREATING MMA |
2018 |
- Venditti, Charles, P.
- Chandler, Randy, J.
- Chau, B. Nelson
- Chiang, Kyle, P.
- Liao, Jing
|
RU2820602C2 |
| COMPOSITIONS AND METHODS FOR DEGRADATION OF IMPROPERLY PACKAGED PROTEINS |
2016 |
|
RU2761564C2 |
| TREATMENT OF COMPLEMENT-MEDIATED DISORDERS |
2017 |
- Lachmann, Peter
- Alexander, Ian
|
RU2768982C2 |
